COFEPRIS definition

COFEPRIS means Mexico’s Federal commission for the Protection Against Sanitary Risk;
COFEPRIS means the Mexican Sanitary Risks Protection Agency (Comisión Federal para la Protección contra Riesgos Sanitarios) and any successor agency thereto.
COFEPRIS. Federal Commission for the Protection against Sanitary Risks. Medical Devices: Medical equipment, prostheses, orthotics, functional aids, diagnostic agents, dental supplies, surgical materials, first-aid materials, hygiene products and other devices for medical use, referred to in Chapter IX Second Title of the Regulation on Health Supplies. Law: General Law on Health. MHLW: The Japanese government entity named the Ministry of Health, Labor and Welfare. PMDA: The Japanese government entity named the Pharmaceuticals and Medical Devices Agency. Regulation: Regulation on Health Supplies. SECOND. Recognition of equivalency with the requirements established in articles 179 and 180 of the Regulation and the procedures carried out by COFEPRIS for the granting of sanitary registries for Class I, II and III Medical Devices in accordance with criteria established in article 83 of the Regulation is given to:

Examples of COFEPRIS in a sentence

  • The previous opinion issued by the COFEPRIS of the Secretariat for Health at the beginning of the validity of the Agreement, through its Comisión de Autorización Sanitaria [Health Authorization Committee], based on Articles 14 sections VI; VII; VIII; 62, sections II, III, IV, V, VI, VII; 64 sections I, II, III, IV, V and 98 of the Regulation of the General Health Act for Health Research.

  • El dictamen previo que emita la Comisión Federal para la Protección contra Riesgos Sanitarios, de la Secretaría de Salud (COFEPRIS) al inicio de la vigencia del Convenio, a través de su Comisión de Autorización Sanitaria, con fundamento en los artículos 14 fracciones VI; VII; VIII; 62, fracciones II, III, IV, V, VI, VII; 64 fracciones I, II, III, IV, V y 98 del Reglamento de ▇▇ ▇▇▇ General de Salud en Materia de Investigación para la Salud.

  • By “THE SPONSOR” at any time, provided that the COFEPRIS is formally notified of the reasons for the early termination of “THE PROTOCOL”, if it has requested authorization for its execution from that authority.

  • The following annexes are part of this Collaboration Agreement: Annex A: Favorable opinion from the COFEPRIS through its Health Authorization Committee; Annex B: Research Protocol; Annex C: Use of RESOURCES; Annex D: Authorization from the Relevant Committees; Annex E: Informed Consent Form; Annex F: Delegation of Powers Letter THIRTY-SIX.

  • El presente Acuerdo finalizará tras la aprobación del Producto en Investigación por parte de la COFEPRIS; para el uso descrito en el Protocolo, no obstante, dicha finalización no se producirá hasta que el paciente hayapasado a utilizar el producto disponible comercialmente a través del seguro del paciente o de un programa de asistencia al paciente de ULTRAGENYX.

  • Any dispute between the Parties regarding specifications of the Product delivered hereunder shall be referred, in the case of Mexico, in first instance to a mutually acceptable third party expert authorized by COFEPRIS, if no agreement is reached between the Parties with respect to such appointment, then such dispute shall be referred to Lambda Científica, S.A. de C.V. or Laboratorios B▇▇▇▇ ▇.▇.

  • In the case that the submitted documents are not complete, COFEPRIS will notify the applicant within a time period equal to a third part of the time period granted to resolve the application, when the problem is of an administrative nature, and two thirds if of a technical nature, based on the terms of the article 156 of the Regulation.

  • Except in the cases mentioned in the following paragraph, COFEPRIS will not require any additional documentation besides that mentioned in the previous article, in order to process the registration application that is submitted on the basis of this Agreement, regardless of the Medical Device country of origin, for whose health registration is being applied.

  • Notwithstanding the above, Ultragenyx will collaborate with the Institution and the Physician to obtain the authorization issued by COFEPRIS for the supply of the Investigational Product.

  • The Target Companies have not received written notice of any investigation, claim or proceeding that is ongoing or being initiated, or threatened to be initiated, by COFEPRIS or any Governmental Authority regarding a breach of a Sanitary License.


More Definitions of COFEPRIS

COFEPRIS means the Mexican Sanitary Risks Protection Agency ( Comisión Federal para la Protección contra Riesgos Sanitarios ) and any
COFEPRIS means Federal Commission for the Protection Against Sanitary Risks (“Comisión Federal para la Protección contra Riesgos Sanitarios”) of the United Mexican States.
COFEPRIS means the Federal Commission for the Protection against Sanitary Risk (Comisión Federal para la Protección contra Riesgos Sanitarios) and any such body or entity, of any nature, that replaces or substitutes it.

Related to COFEPRIS

  • TFEU means the Treaty on the Functioning of the European Union;

  • NZME means all companies in the NZME Group including but not limited to APN Holdings NZ Limited, NZME. Publishing Limited, NZME. Radio Limited, GrabOne Limited and all brands and operating companies controlled by or associated with those entities.

  • FOISA means the Freedom of Information (Scotland) ▇▇▇ ▇▇▇▇ and any subordinate legislation made under this Act from time to time or any superseding or amending enactments or regulations, together with any guidance and/or codes of practice issued by the Information Commissioner, the Scottish Information Commissioner and/or any relevant government department in relation to such legislation.

  • IMRO means the Irish Music Rights Organisation CLG.

  • SAQA means the South African Qualifications Authority;